• Users Online: 321
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2022| January-March  | Volume 5 | Issue 1  
    Online since March 30, 2022

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
REVIEWS
The diverse landscape of histone-mutant pediatric high-grade gliomas: A narrative review
Evan Lubanszky, Cynthia Hawkins
January-March 2022, 5(1):5-11
DOI:10.4103/glioma.glioma_1_22  
  1,784 165 -
COMMENTARY
New changes in pathological diagnosis of brain tumors in the modern molecular era
Zhi Li
January-March 2022, 5(1):1-4
DOI:10.4103/glioma.glioma_7_22  
  1,644 147 -
REVIEWS
Glioma stem cells and their microenvironment: A narrative review on docking and transformation
Wenyu Zhu, Hua Chen, Ke Yan, Jie Wu, Yaodong Zhao, Qiang Huang
January-March 2022, 5(1):12-19
DOI:10.4103/glioma.glioma_5_22  
  1,470 141 -
ORIGINAL ARTICLES
A novel nomogram based on DNA damage response-related gene expression in patients with O-6-methylguanine-DNA methyltransferase unmethylated glioblastoma receiving temozolomide chemotherapy: A population-based analysis
Rong Wang, Yingpeng Peng, Wei Wei, Yuling Zhou, Xiaonan Li, Yunfei Xia, Zhigang Liu
January-March 2022, 5(1):20-28
DOI:10.4103/glioma.glioma_3_22  
  950 94 -
Initial report of a clinical trial evaluating the safety and efficiency of neoadjuvant camrelizumab and apatinib in patients with recurrent high-grade gliomas: A prospective, phase II, single-arm study
Fuhua Lin, Chengcheng Guo, Qunying Yang, Yinsheng Chen, Chao Ke, Ke Sai, Ji Zhang, Xiaobing Jiang, Wanming Hu, Shaoyan Xi, Jian Zhou, Depei Li, Zhihuan Zhou, Qinqin Zhao, Xi Cao, Zhong-ping Chen
January-March 2022, 5(1):29-38
DOI:10.4103/glioma.glioma_6_22  
  925 104 -
CASE REPORT
Tumor growth, angiogenesis, and invasion as clinical hallmarks of glioblastoma: A case report
Eric T Wong
January-March 2022, 5(1):39-42
DOI:10.4103/glioma.glioma_2_22  
  748 83 -